Yaron Werber
Stock Analyst at TD Cowen
(0.96)
# 3,754
Out of 4,901 analysts
37
Total ratings
30.77%
Success rate
-12.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines | Reiterates: Buy | $334 | $279.16 | +19.64% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $9.65 | - | 1 | Jan 21, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | n/a | $19.86 | - | 1 | Dec 20, 2024 | |
| SEPN Septerna | Initiates: Buy | n/a | $11.99 | - | 1 | Nov 19, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $160 → $153 | $175.40 | -12.77% | 5 | Nov 15, 2024 | |
| BNTX BioNTech SE | Maintains: Hold | $132 → $122 | $112.49 | +8.45% | 5 | Nov 6, 2024 | |
| UPB Upstream Bio | Initiates: Buy | n/a | $10.92 | - | 1 | Nov 5, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $61 → $73 | $27.31 | +167.30% | 2 | Oct 21, 2024 | |
| EXEL Exelixis | Maintains: Buy | $27 → $34 | $44.81 | -24.12% | 2 | Oct 21, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $54 → $59 | $42.77 | +37.95% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $39.75 | +68.55% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $11.90 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.35 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.96 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.98 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $612 → $641 | $577.92 | +10.92% | 3 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.57 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $375 → $625 | $7.52 | +8,211.17% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $25.68 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $21.87 | +73.75% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.89 | - | 1 | Nov 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.54 | - | 1 | Oct 26, 2021 |
BeOne Medicines
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $279.16
Upside: +19.64%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $9.65
Upside: -
Dianthus Therapeutics
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $19.86
Upside: -
Septerna
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $11.99
Upside: -
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $175.40
Upside: -12.77%
BioNTech SE
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $112.49
Upside: +8.45%
Upstream Bio
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $10.92
Upside: -
Ultragenyx Pharmaceutical
Oct 21, 2024
Maintains: Buy
Price Target: $61 → $73
Current: $27.31
Upside: +167.30%
Exelixis
Oct 21, 2024
Maintains: Buy
Price Target: $27 → $34
Current: $44.81
Upside: -24.12%
Ionis Pharmaceuticals
Jul 23, 2024
Maintains: Buy
Price Target: $54 → $59
Current: $42.77
Upside: +37.95%
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $39.75
Upside: +68.55%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $11.90
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $3.35
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $3.96
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $22.98
Upside: -
Dec 12, 2023
Maintains: Outperform
Price Target: $612 → $641
Current: $577.92
Upside: +10.92%
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $0.57
Upside: -
Feb 28, 2023
Maintains: Market Perform
Price Target: $375 → $625
Current: $7.52
Upside: +8,211.17%
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $25.68
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $21.87
Upside: +73.75%
Nov 30, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.89
Upside: -
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.54
Upside: -